Antigen-specific immunotherapy is effective for changing the natural course of allergic rhinitis, preventing development of other allergic diseases, and reducing new sensitization to allergen. Subcutaneous immunotherapy SCIT has been conducted over the years, but it is associated with a risk of anaphylactic shock, albeit low, and the inconvenience of frequent visits to hospital. While, sublingual immunotherapy SLIT, according to recent reviews, is safe and effective as an alternative route of administration. So, SLIT is expected to be introduced in Japan.
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To clarify the efficacy of SLIT for Japanese cedar pollinosis, we have conducted several clinical trials and therapeutic efficacy has been suggested. No major adverse effects were observed in all studies. SLIT is one of the most expected treatments, but includes some problems. Objective biomarkers that show the therapeutic efficacy have not been established. Therefore, it is necessary to identify relevant biomarkers for monitoring efficacy. Then, we tried to find the therapeutic biomarkers of SLIT. We focused on the antigen specific Th cells, and antigen specific induced regulatory T cells iTreg cells as the candidates from the mechanism. A significant increase in specific Th clone was observed only in the placebo group after the pollen season, but no significant change was observed in active SLIT group. Nose-blowing and sneezing appeared during pollen exposure in the ECC and hours after leaving ECC. But even hours after leaving ECC, rhinorrhea and sneezing were observed continuously. It has been thought that rhinorrhea and sneezing are induced by histamine. Then histamine levels in nasal discharge were examined. Interestingly, a substantial amount of histamine was detected in nasal discharge from almost examinee even hours after leaving ECC. Then we examined the cells in nasal discharge with confocal microscopy.
Basophiles were increased in nasal discharge. So, it is assumed that an accumulation of basophile is involved in histamine release causing in sneezing and rhinorrhea in the late phase.
